MTOR and prostate cancer: In conclusion, we have described a novel resistance mechanism to PI3K-AKT-mTOR inhibition in PTEN-wt prostate cancer cell lines, involving HER receptors, PSMA and mGluR1 in a regulatory loop (Fig. 5).